27 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Genovese, Rheumatologist in Stanford, CA?
Dr. Mark Genovese, MD is a Rheumatologist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 27 years. Dr. Genovese is fluent in English, and is currently seeing new patients. Dr. Genovese’s practice accepts Medicaid, Medicare, Aetna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Genovese’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Genovese?
Dr. Mark Genovese, MD is a highly-rated, board-certified Rheumatologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Genovese empowers patients to confidently navigate their health journey, specializing in Arthritis, Autoimmune Disease, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Genovese is dedicated to enhancing lives through expert, patient-centered care.
What languages does Dr. Genovese speak?
Dr. Genovese and their clinical team can communicate with patients in the following languages:
English
What conditions does a Rheumatologist like Dr. Genovese typically treat?
As a Rheumatologist, Dr. Genovese diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Genovese. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Rheumatoid Arthritis
- Adult-Onset Still's Disease
- Juvenile Arthritis
- RA
- Inflammatory Arthritis
- Autoimmune Arthritis
- Chronic inflammatory arthritis
- Autoimmune arthritis
- Inflammatory joint disease
- Still's Disease (Adult Form)
- Systemic Juvenile Idiopathic Arthritis (Adult)
- Adult Still's Syndrome
- AOSD
ICD-10 Codes:
- M0560: Rheumatoid arthritis of unspecified site with involvement of other organs and systems
- M069: Rheumatoid arthritis, unspecified
- M061: Adult-onset Still's disease
Also known as:
- Psoriatic Arthritis
- Psoriasis
- Psoriatic joint inflammation
- Arthritis with psoriasis
- Psoriasis-related joint pain
ICD-10 Codes:
- L4050: Arthropathic psoriasis, unspecified
Also known as:
- Granulomatous Mastitis in Left Breast
- Breast Disease
- Left breast inflammatory condition
- Left breast granulomatous disease
- Left breast non-infectious mastitis
ICD-10 Codes:
- N6122: Granulomatous mastitis, left breast
Also known as:
- Secondary Multiple Joint Arthritis
- Osteoarthritis
- Secondary Polyarthritis
- Multiple Joint Inflammation
- Secondary Widespread Arthritis
ICD-10 Codes:
- M153: Secondary multiple arthritis
What procedures does a Rheumatologist like Dr. Genovese typically perform?
As a Rheumatologist, procedures performed by Dr. Mark Genovese may include:
- Abnormal ANA Testing
- Arthrocentesis
- Denosumab Injection
- Joint Aspiration
- Joint Injections
- Rheumatology Consultation
- Rheumatology Follow Up
- Viscosupplement Injections
Please contact Dr. Genovese's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Genovese accept my insurance?
Dr. Genovese accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Genovese accept in Stanford, CA?
Dr. Genovese in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Elevance Health Inc. (formerly Anthem)
Medicaid
Medicare
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Genovese's office located?
Recognitions
Publications
Novel small molecule therapeutics in rheumatoid arthritis
, 2013
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis
, 2013
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding
, 2013
Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized
, 2013
Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kise Inhibitor
, 2013
Tabalumab in Rheumatoid Arthritis Patients With an Idequate Response to Methotrexate
, 2013
Effects of sclerostin antibody on healing of a non-critical size femoral bone defect
, 2013
Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid
, 2012
Effect of Golimumab on Patient-reported Outcomes in Rheumatoid Arthritis
, 2012
Tabalumab, an anti-BAFF monoclol antibody
Subcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study
, 2011
Atacicept in Patients With Rheumatoid Arthritis
, 2011
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of
, 2011
An Oral Syk Kise Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized
, 2011
LY2439821, a Humanized Anti-Interleukin-17 Monoclol Antibody
, 2010
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
, 2009
First Report of Idiopathic Granulomatous Mastitis Treated with Methotrexate Monotherapy
, 2009
Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy
, 2009
Efficacy of a p38 mitogen activated protein kise inhibitor
, 2009
Inhibition of p38: Has the Fat Lady Sung
, 2009
Blood autoantibody and cytokine profiles predict response to anti
, 2009
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis
, 2008
Ocrelizumab, a humanized anti-CD20 monoclol antibody
, 2008
Efficacy and safety of the selective co
, 2008
Efficacy results from pivotal clinical trials with abatacept
, 2007
A pilot trial of rituximab in the treatment of patients with dermatomyositis
, 2007
Proteomic alysis of secreted proteins in early rheumatoid arthritis
, 2007
A pilot study of tumor necrosis factor inhibition in erosive
, 2007
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed
, 2007
Selective tyrosine kise inhibition by imatinib mesylate for the treatment of autoimmune arthritis
, 2006
A randomized, blinded
, 2005
Magement of co-morbidities and general medical conditions in patients with rheumatoid arthritis.
, 2005
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition
, 2005
Antigen microarray profiling of autoantibodies in rheumatoid arthritis
, 2005
Longterm safety, efficacy
, 2005
Factors that predict prematurity
, 2005
Biologic therapies in clinical development for the treatment of rheumatoid arthritis
, 2005
Temporal effects of a COX-2-selective NSAID on bone ingrowth
, 2005
Pharmacologic modulation of periprosthetic osteolysis
, 2005
Associations between rheumatoid arthritis and maligncy
, 2004
Combition therapy with etanercept
, 2004
Treatment of rheumatoid arthritis with etanercept
, 2004
Unlocking the PAD lock on rheumatoid arthritis
, 2004
A randomized, controlled trial of interferon-beta
, 2004
Interleukin 1 receptor antagonist inhibits localized bone formation in vivo
, 2003
COX-2 selective inhibitors and bone
, 2003
Imaging of the articular cartilage in osteoarthritis of the knee joint
, 2003
Modulation of bone ingrowth
, 2003
Rheumatic syndromes associated with maligncy
, 2003
COX-2 selective NSAID decreases bone ingrowth in vivo
, 2002
Central nervous system lupus and pregncy: 11-year experience at a single center.
, 2002
Etanercept versus methotrexate in patients with early rheumatoid arthritis - Two
, 2002
Long-term followup of patients treated with total lymphoid irradiation for lupus nephritis
, 2002
Autoantigen microarrays for multiplex characterization of autoantibody responses
, 2002
Expression of the chemokine receptors CCR4, CCR5
, 2002
Rules of chemokine receptor association with T cell polarization in vivo
, 2001
Demyeliting and neurologic events reported in association with tumor necrosis factor alpha
, 2001
Treatment of rheumatoid arthritis with total lymphoid irradiation - Long-term survival
, 2001
Bonzo/CXCR6 expression defines type 1
, 2001
Current magement of rheumatoid arthritis
, 2001
Cutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal
, 2000
Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine
, 2000
Joint and soft-tissue injection - A useful adjuvant to systemic and local treatment
, 1998
Fever, rash, and arthritis in a woman with silicone gel breast implants
, 1997
Lemierre's syndrome
, 1997
What is Dr. Genovese's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Genovese's National Provider Identifier (NPI) number is 1487711875.
What common questions do patients ask about Dr. Genovese?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Genovese
What is Dr. Mark Genovese's specialty?
Dr. Genovese is a Rheumatologist near Stanford, CA.
What does a Rheumatologist do?
An internist specializing in the treatment of diseases affecting the joints, muscles, bones, and tendons. This specialist diagnoses and manages conditions such as arthritis, back pain, muscle strains, common sports injuries, and collagen-related diseases.
Is this Dr. Mark Genovese affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Genovese is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Rheumatologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Rheumatologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Mark Genovese accepting new patients in Stanford, CA?
Yes, Dr. Mark Genovese is accepting new patients at this time.
Does Dr. Mark Genovese offer online booking?
Please contact Dr. Genovese's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Mark Genovese?
Please contact Dr. Genovese's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Other Rheumatologist Near Stanford, CA
Rheumatologist
Accepting patients
Rheumatologist
Accepting patientsRheumatologist
Accepting patients